BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9890740)

  • 1. The surgical treatment of medullary thyroid carcinoma.
    Evans DB; Fleming JB; Lee JE; Cote G; Gagel RF
    Semin Surg Oncol; 1999; 16(1):50-63. PubMed ID: 9890740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management and follow-up of medullary thyroid carcinoma.
    Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
    J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
    Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
    Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma: state of the art.
    Favia G; Iacobone M
    G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes.
    Wells SA; Skinner MA
    Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.
    Morris LF; Waguespack SG; Edeiken-Monroe BS; Lee JE; Rich TA; Ying AK; Warneke CL; Evans DB; Perrier ND; Grubbs EG
    Ann Surg Oncol; 2013 Jan; 20(1):53-9. PubMed ID: 22890595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical therapy of medullary thyroid carcinoma.
    Sturniolo G; Bonanno L; Gagliano E; Tonante A; Taranto F; Mamo M; De Salvo G; Sturniolo G
    Chir Ital; 2007; 59(6):781-7. PubMed ID: 18360982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.
    Zenaty D; Aigrain Y; Peuchmaur M; Philippe-Chomette P; Baumann C; Cornelis F; Hugot JP; Chevenne D; Barbu V; Guillausseau PJ; Schlumberger M; Carel JC; Travagli JP; Léger J
    Eur J Endocrinol; 2009 May; 160(5):807-13. PubMed ID: 19240193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of medullary thyroid cancer.
    Mazeh H; Sippel RS
    Minerva Endocrinol; 2012 Dec; 37(4):329-34. PubMed ID: 23235189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma in Northern Ireland, 1967-1997.
    Dolan SJ; Russell CF
    Ann R Coll Surg Engl; 2000 May; 82(3):156-61. PubMed ID: 10858675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical procedure in children with medullary thyroid gland carcinoma with reference to multiple endocrine neoplasia type II].
    Schäfer K; Senninger N; Roth H; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():202-4. PubMed ID: 9101831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.